Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Hubbell to Participate in Upcoming Investor Conference
-
President & CEO Letter to Shareholders
-
Ero Copper Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
-
Federman & Sherwood Investigates Bay Cove Human Services for Data Breach
-
Nova Leap Health Corp. Posts Fourth Quarter and 2024 Annual Financial Results Including Record Adjusted EBITDA for 2nd Consecutive Year
-
Martinrea International Inc. Reports Year End and Fourth Quarter Results and Announces Dividend
-
TWC Enterprises Limited Announces 2024 Year End Results and Increase in Eligible Dividend
-
Major Drilling Announces Third Quarter 2025 Results
-
Total Energy Services Inc. Announces Q4 2024 Results
-
ArtGee Finance Fund: A Technological Revolution Redefining Crypto Asset Management—— A Financial Paradigm Shift Inspired by Artistic Genes
-
Sprott Announces Renewal of Normal Course Issuer Bid
-
BE Resources Announces Debt Settlement
-
BellRing Brands Announces New Share Repurchase Authorization of $300 Million
-
Tarsus to Participate in Upcoming Investor Conference
-
Geek Bar Wins the 2025 iF DESIGN AWARD for Two Innovative Concept Products
-
Raw Garden Introduces Sprout™ Vape, Pioneering Terpene-Safe Plastic for Cannabis Hardware
-
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting
-
VALHI REPORTS FOURTH QUARTER 2024 RESULTS
-
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
Palomar Holdings, Inc. to Host Investor Day
-
Federman & Sherwood Investigates the Center for Digestive Health for Data Breach
-
In NCLA Amicus Win, D.C. Circuit Recognizes President Trump’s Right to Fire Principal Officer
-
Diamondback Energy Prices Offering of Senior Notes
-
Constellation Brands to Report Full Fiscal Year and Fourth Quarter 2025 Financial Results on April 9, 2025 After Market Close and Host Conference Call April 10, 2025 at 10:30AM ET
-
Gold Bull Announces Shareholder Approval, Receipt of Court Approval and Expected Closing Date of Borealis Arrangement
-
Helmets to Hardhats Expands Support for Veterans and Military Families Through Funding from Veterans Affairs Canada
-
IDT Corporation Reports Record Second Quarter 2025 Results
-
Graphjet Technology Discloses Notice from Nasdaq
-
Monthly information on share capital and company voting rights
-
NL REPORTS FOURTH QUARTER 2024 RESULTS
-
LBMC Experts Highlight 2025 Technology Industry Trends
-
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025
-
Bimini Capital Management Announces Fourth Quarter 2024 Results
-
Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
-
Global Ship Lease Declares Quarterly Dividend on its 8.75% Series B Cumulative Redeemable Perpetual Preferred Shares
-
Clarus Reports Fourth Quarter and Full Year 2024 Results
-
California Water Service Group Invests $471 Million in Infrastructure in 2024 to Make Water Systems Safer, More Resilient
-
Comstock Announces Full Year 2024 Results
-
Cohen & Company Sets Release & Conference Call Date for Fourth Quarter & Full Year 2024 Financial Results
-
Powell Industries Announces Participation in Upcoming Investor Events
-
KRONOS WORLDWIDE, INC. REPORTS FOURTH QUARTER 2024 RESULTS
-
CooperCompanies Announces First Quarter 2025 Results
-
VALHI DECLARES QUARTERLY DIVIDEND
-
Cohen & Company Sets Release & Conference Call Date for Fourth Quarter & Full Year 2024 Financial Results
-
Costco Wholesale Corporation Reports Second Quarter and Year-To-Date Operating Results For Fiscal 2025 and February Sales Results
-
Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting
-
Ambia Energy Wins Gold Stevie® Award in 2025 Stevie Awards for Sales & Customer Service
-
New study links sports gambling with alcohol-related risks over time
-
Theriva™ Biologics Reports Full-Year 2024 Operational Highlights and Financial Results
-
CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

